checkAd
    Recursion Pharmaceuticals Registered (A)
    Aktie
    ISIN: US75629V1044 WKN: A3CM1C SYM: RXRX Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    9,2600
     
    USD
    -1,91 %
    -0,1800 USD
    Letzter Kurs 02:00:00 Nasdaq
    Geldkurs
    14.06.24
    9,2800
     
    USD
    1.700 STK
    Briefkurs
    14.06.24
    9,2900
     
    USD
    18.800 STK

    Recursion Pharmaceuticals Registered (A) Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Aktie vor "rascher Umkehr"?: Cathie Wood warnt: Nvidia braucht Unterstützung für anhaltenden Kurs-Boom(4) 
    07.06.24 · wallstreetONLINE Redaktion · NVIDIA
    Recursion to Participate in Upcoming Investor Conferences
    03.06.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
    29.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
    24.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry
    13.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Provides Business Updates and Reports First Quarter 2024 Financial Results
    09.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
    02.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Participate in Upcoming Investor Conferences
    01.05.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
    30.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
    16.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion to Participate in Upcoming Investor Conference
    02.04.24 · globenewswire · Recursion Pharmaceuticals Registered (A)
    Recursion Publishes Annual Environmental, Social and Governance Report
    26.03.24 · globenewswire · Recursion Pharmaceuticals Registered (A)